Amedisys, Inc. (NASDAQ: AMED) has acquired all the assets of Tulsa, Okla.-based RoseRock Healthcare, a provider of specialized hospice care to approximately 220 patients daily in northeastern Oklahoma, for an undisclosed sum.
“Whether we’re delivering care at a patient’s bedside, supporting our clinical team or educating the community on the hospice benefit, hospice isn’t just a job; it’s our calling,” said Regarner Thompson, Amedisys’ senior vice president of Hospice, South Region. “We know our patients and our team members will benefit by coming together with a strongly aligned culture and commitment to excellent patient care.”
With the RoseRock transaction, Amedisys will operate 138 hospice care centers in 34 states. The Louisiana-based company became the third largest hospice care provider in the United States with the $340 million acquisition of Compassionate Care Hospice in February.
In addition to its new Oklahoma hospice holdings, Amedisys currently operates six home health care centers in the state, including an agency in Tulsa.
“We are so excited to have the privilege of continuing the RoseRock tradition of honoring life with the best care possible to the Tulsa community,” said Amedisys President and Chief Executive Officer Paul Kusserow.
Industry observers such as the Braff Group and Mertz-Taggart have predicted that mergers and acquisitions will continue to be a leading growth strategy in the hospice market during 2019 and beyond.
Amedisys earlier this year indicated that acquisitions will continue to be a key growth strategy for the company throughout 2019 and likely beyond.
“Capital deployment on hospice acquisitions remains our first priority,” CEO Paul Kussarow said.
Companies featured in this article:
